Cargando…

Immune control in chronic myeloid leukemia

Detalles Bibliográficos
Autores principales: Ilander, Mette, Mustjoki, Satu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732686/
https://www.ncbi.nlm.nih.gov/pubmed/29262520
http://dx.doi.org/10.18632/oncotarget.22279
_version_ 1783286755830530048
author Ilander, Mette
Mustjoki, Satu
author_facet Ilander, Mette
Mustjoki, Satu
author_sort Ilander, Mette
collection PubMed
description
format Online
Article
Text
id pubmed-5732686
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57326862017-12-19 Immune control in chronic myeloid leukemia Ilander, Mette Mustjoki, Satu Oncotarget Editorial Impact Journals LLC 2017-11-03 /pmc/articles/PMC5732686/ /pubmed/29262520 http://dx.doi.org/10.18632/oncotarget.22279 Text en Copyright: © 2017 Ilander et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Ilander, Mette
Mustjoki, Satu
Immune control in chronic myeloid leukemia
title Immune control in chronic myeloid leukemia
title_full Immune control in chronic myeloid leukemia
title_fullStr Immune control in chronic myeloid leukemia
title_full_unstemmed Immune control in chronic myeloid leukemia
title_short Immune control in chronic myeloid leukemia
title_sort immune control in chronic myeloid leukemia
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732686/
https://www.ncbi.nlm.nih.gov/pubmed/29262520
http://dx.doi.org/10.18632/oncotarget.22279
work_keys_str_mv AT ilandermette immunecontrolinchronicmyeloidleukemia
AT mustjokisatu immunecontrolinchronicmyeloidleukemia